Cardiovascular disease (CV) remains the leading cause of death in Spain, contributing to disability and healthcare costs. The Spanish Society of Arteriosclerosis released the 2026 edition […]

Even subclinical levels of primary aldosteronism can have an important impact on cardiovascular (CV) disease and could offer a potential target for risk reduction, according to […]

Apixaban reduced the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism (VTE), the randomized COBRRA trial found, confirming observational and indirect […]

Children with worse oral health were more likely to experience heart attack, stroke, or coronary artery disease as adults, according to a new study based on […]

A teenage footballer who died after collapsing during a match was not given immediate life support because the 999 call handler and those present on the […]

GLP-1 receptor agonists such as semaglutide are changing the way type 2 diabetes and obesity are treated. But these drugs have also shown a surprising ability […]

Aspirin’s use in primary prevention has narrowed sharply in recent years, but new findings suggested an important new role: reducing risk for aortic stenosis in people […]